Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
15 Results Found
4 Insights into Walgreens’ Health Strategy Review
New Walgreen's CEO Tim Wentworth said he and the board will meet in April to conduct a strategic review of Walgreens’ retail, pharmacy and health care business portfolio and to develop a road map for the future.
Grapefruit Health Targets a New Way to Address the Field’s Workforce Shortage
Ballad Health in Johnson City, Tennessee, recently completed an interesting pilot to improve communication around medication adherence. It worked with Grapefruit Health, a startup focused on addressing health care’s staffing shortage by creating a workforce solely comprising clinical students.
IV Strategies for Disruptions - How to Guide
Toolkits/Methodology
How-to guide to managing IV disruptions.
Download Tool
3 Takeaways from the HLTH Conference
Amid the sound bites and substance delivered at the recent HLTH conference, health care leaders, transformers and innovators shared how they plan to reshape care delivery, partner to drive innovation and help consumers get greater access to obesity and diabetes medications along with a greater holistic focus on weight management.
Will Blue Shield’s New Pharma Model Disrupt the PBM Market?
A new plan will transition Blue Shield of California’s drug supply management from CVS Health’s PBM to five companies — a move the payer believes will save its 4.8 million members as much as $500 million a year in drug costs or about 10% to 15% of what it spends on drugs annually.
Civica Rx Gets More Backing in Effort to Reduce Drug Prices and Shortages
The state of California put up $50 million to have Civica Rx manufacture and distribute low-cost biosimilars for the three most used short- and long-acting insulins.
3 Ways Pharma Could Jolt Health Care in 2023
The market for biosimilar drugs to treat cancer, inflammatory diseases, diabetes and more will continue to expand, ideally resulting in lower prices as more pharmaceutical patents expire and competitors enter the market.
4 Key Predictions for Health Care in 2023 and How to Respond
In 2023, provider organizations can expect significant evolutionary changes in how to optimize patient engagement, the ever-expanding role that retail clinics will play in care delivery and some upheaval in venture capital funding for health care startups.
Alexa Can Now Answer Questions about 1,500 Most-Prescribed Drugs
Amazon continues to grow its partnerships with health care technology companies as it expands its access points with consumers. The latest move: a deal with drug and medical database company First Databank (FDB) that will allow Amazon’s Alexa voice-assistant users to ask for information on the 1,500 most commonly prescribed drugs in the U.S.